INSIGHTS ON CLINICAL TRIAL PARTNERING
-
How To Select The Right Bioanalysis CRO For Your Program
The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?
-
Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch
Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials
A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.
-
Early-Stage Biotech's AI Advantage Is A Window That Closes
The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.
-
New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations7/17/2025
Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.
-
Empowering Mid-Size Pharma Companies With Integrated Drug Development, Regulatory Strategy, And AI Innovation10/23/2025
A consultative, tech-enabled CRO can help mid-size pharma achieve targets by supplementing skillsets, expanding global reach, and designing an effective clinical, regulatory, and operational strategy.
-
High Density, Low Availability: Rethinking Ophthalmic Trial Readiness4/16/2025
The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
Building A Gold Standard Trial Experience In Japan4/4/2025
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
Flipping The Drug Development Industry On Its Head6/18/2024
The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
Our aim is to ensure the flawless and successful execution of clinical research, maximizing its impact on both patients and the commercial market.
-
Whether you need a few scientific experts or a fully-staffed function, gain flexibility and results with Veristat’s Strategic Resourcing Solution and confidently meet your study milestones.
-
Solve the unique challenges of poorly soluble molecules like targeted protein degraders (TPDs), such as PROTACs and molecular glues, seamlessly accelerating your molecule from development to commercialization.